Literature DB >> 16385844

Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles.

Peter Plomgaard1, Milena Penkowa, Bente K Pedersen.   

Abstract

Skeletal muscle is now recognized as an endocrine organ with the capacity to produce signal peptides in response to muscle contractions. Here we demonstrate that resting healthy human muscles express cytokines in a fiber type specific manner. Human muscle biopsies from seven healthy young males were obtained from m. triceps, m. quadriceps vastus lateralis and m. soleus. Type I fibers contributed (mean +/- SE) 24.0 +/- 2.5% in triceps of total fibers, 51.3 +/- 2.4% in vastus and 84.9 +/- 22% in soleus. As expected, differences in the fiber type composition were accompanied by marked differences between the three muscles with regard to MHC I and MHC IIa mRNA expression. Immunohistochemistry demonstrated that tumor necrosis factor (TNF)-alpha and interleukin (IL)-18 were solely expressed by type II fibers, whereas the expression of IL-6 was more prominent in type I compared to type II fibers. The fiber type specificity was found in triceps, vastus and soleus indicating that the level of daily muscle activity did not influence basal cytokine expression. The specificity of cytokine expression in different muscle fiber types in healthy young males suggests that cytokines may play specific regulatory roles in normal physiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385844

Source DB:  PubMed          Journal:  Exerc Immunol Rev        ISSN: 1077-5552            Impact factor:   6.308


  42 in total

Review 1.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

2.  Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered Myobundles.

Authors:  Brittany N J Davis; Jeffrey W Santoso; Michaela J Walker; Catherine E Oliver; Michael M Cunningham; Christian A Boehm; Danielle Dawes; Samantha L Lasater; Kim Huffman; William E Kraus; George A Truskey
Journal:  Ann Biomed Eng       Date:  2019-04-08       Impact factor: 3.934

Review 3.  Lipotoxicity, aging, and muscle contractility: does fiber type matter?

Authors:  Christy S Carter; Jamie N Justice; LaDora Thompson
Journal:  Geroscience       Date:  2019-06-22       Impact factor: 7.713

Review 4.  Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

5.  Influence of the sample collection method on salivary interleukin-6 levels in resting and post-exercise conditions.

Authors:  M A Minetto; M Gazzoni; F Lanfranco; M Baldi; L Saba; R Pedrola; P V Komi; A Rainoldi
Journal:  Eur J Appl Physiol       Date:  2007-06-14       Impact factor: 3.078

6.  Immune and Inflammatory Signaling Pathways in Exercise and Obesity.

Authors:  Karsten Krüger; Frank C Mooren; Klaus Eder; Robert Ringseis
Journal:  Am J Lifestyle Med       Date:  2014-10-27

7.  Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses.

Authors:  Heidi E Banse; Todd C Holbrook; Nicholas Frank; Dianne McFarlane
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

8.  Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy.

Authors:  Benjamin T Barnes; Amy L Confides; Mark M Rich; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2015-03-05       Impact factor: 2.698

9.  Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFalpha, in mice lacking interleukin-10.

Authors:  Kimberly A Huey; Robert H McCusker; Keith W Kelley
Journal:  J Neuroimmunol       Date:  2008-06-18       Impact factor: 3.478

Review 10.  The role of interleukin-18 in the metabolic syndrome.

Authors:  Marius Trøseid; Ingebjørg Seljeflot; Harald Arnesen
Journal:  Cardiovasc Diabetol       Date:  2010-03-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.